Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03555630 · ClinicalTrials.gov registry record
Thromboelastogram in Postdelivery Preeclamptic Patients
A clinical trial, sponsored by Augusta University.
- Completed
- Registry status
- 30
- Enrollment target
NCT03555630: Completed study, sponsored by Augusta University.
NCT03555630 is a clinical trial that has completed, run by Augusta University. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03555630 has completed, sponsored by Augusta University.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
There are no studies evaluating the effect of aging on hemostasis of preeclamptic patients. Additionally, although there are some studies that establish normal reference values for TEG profiles in healthy term pregnant patients, conflicting results have been found in preeclampsia. Reference values are important to establish baseline parameters in cases of pre-eclampsia complicated by postpartum hemorrhage. The investigators will evaluate reference values for TEG in postdelivery preeclamptic patients and the difference between vaginal delivery and cesarean section.
Primary Outcome
Reaction time of whole blood
Interventions
- DIAGNOSTIC_TEST Thromboelastogram
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2018-05-22 |
| Est. Completion | 2019-12-31 |
What the finished NCT03555630 record still lists
NCT03555630 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Thromboelastogram is the first listed.
NCT03555630 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03555630 about?
NCT03555630 is a clinical study titled "Thromboelastogram in Postdelivery Preeclamptic Patients". There are no studies evaluating the effect of aging on hemostasis of preeclamptic patients. Additionally, although there are some studies that establish normal reference values for TEG profiles in healthy term pregnant patients, conflicting results have been found in preeclampsia. Reference values a...
What is the current status of trial NCT03555630?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2018-05-22. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT03555630?
The interventions under investigation include: Thromboelastogram (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03555630?
This trial is sponsored by Augusta University, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI